After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
IDYA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Ideaya Biosciences Inc is $2.99B. A total of 0.62 million shares were traded on the day, compared to an average of 708.79K shares.
In the most recent transaction, Hata Yujiro S sold 23,557 shares of IDYA for 45.54 per share on Feb 09 ’24. After the transaction, the President and CEO now owns 677,887 company shares. In a previous transaction on Feb 09 ’24, Ruiz Briseno Andres sold 2,000 shares at 46.02 per share. IDYA shares that the insider owns now total 24,531.
Among the insiders who sold shares, Hata Yujiro S disposed of 75,815 shares on Feb 08 ’24 at a per-share price of $45.15. This resulted in the President and CEO holding 677,887 shares of IDYA after the transaction. In another insider transaction, Hata Yujiro S sold 628 shares at $45.00 per share on Feb 01 ’24. Company shares held by the President and CEO now total 677,887.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, IDYA has a high of $47.74 and a low of $18.09.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. IDYA’s latest balance sheet shows that the firm has $246.77M in Cash & Short Term Investments as of fiscal 2021. There were $5.18M in debt and $45.16M in liabilities at the time. Its Book Value Per Share was $9.55, while its Total Shareholder’s Equity was $301.51M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IDYA is Buy with a score of 4.91.
